Records containing: Hemophilia B

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

• CLINICAL_TRIALS study record update · 2013-03-27
  A Prospective Randomized Pilot Study on the Effect of Patient Counseling on Adolescent Hemophilia Patient Compliance With Bleeding Logs
• CLINICAL_TRIALS study record update · 2013-02-18
  In Vitro Evaluation Of Allergic Reactions In Hemophilia B Subjects Who Have Exhibited A Systemic Allergic Response After Exposure To BeneFIX (Nonacog Alfa; Recombinant Factor IX)
• CLINICAL_TRIALS study record update · 2013-01-30
  Liver Transplantation in Haemophilia Patients in Spain
• CLINICAL_TRIALS study record update · 2012-12-10
  Females With Severe or Moderate Hemophilia A or B: an International Multi-center Study
• CLINICAL_TRIALS study record update · 2012-12-10
  Females With Severe or Moderate Hemophilia A or B: A Multi-Center Study
• Organize your saved records without ads with Plus.
• CLINICAL_TRIALS study record update · 2012-01-31
  An Open-label, Multicenter, Dose-Escalation Safety and Pharmacokinetic Study of a Recombinant Coagulation Factor IX Albumin Fusion Protein (rIX-FP) in Subjects With Hemophilia B
• CLINICAL_TRIALS study record update · 2011-08-23
  A Multicenter, Open-Label Study To Compare On-Demand Treatment With 2 Prophylaxis Regimens of Recombinant Coagulation Factor IX (BeneFIX) Reformulated Drug Product (rFIX-R) In Subjects With Severe Hemophilia B
• CLINICAL_TRIALS study record update · 2011-01-04
  An Evaluation Of The Safety And Efficacy Of On-Demand Treatment With BeneFIX (Nonacog Alfa, Recombinant Factor IX) In Chinese Subjects With Hemophilia B
• CLINICAL_TRIALS study record update · 2010-06-29
  Reformulated BeneFIX Efficacy and Safety After Conversion From a pdFIX
• CLINICAL_TRIALS study record update · 2010-05-26
  A Prospective Registry of European Hemophilia B Patients Receiving BeneFIX®(Nonacog Alfa, Recombinant Human Factor IX) for Usual Use
• CLINICAL_TRIALS study record update · 2009-08-21
  An Open-label Safety and Efficacy Study of Recombinant Human Factor IX (rFIX; BeneFIX®) in Previously Treated Patients (PTPs) With Hemophilia B (FIX:C ≤2%)
• CLINICAL_TRIALS study record update · 2007-12-27
  An Open-Label, Single-Arm, Safety and Efficacy Study of Recombinant Human Factor IX (rFIX; BeneFIX®) in Children Less Than 6 Years of Age With Severe Hemophilia B
• CLINICAL_TRIALS study record update · 2007-12-27
  Evaluation of Efficacy and Safety of Benefix®- Coagulation Factor ix, Recombinant, in Previously Treated Patients With Hemophilia b.
• CLINICAL_TRIALS study record update · 2007-12-27
  Actual Approach to Treatment of Haemophilia A and B in Spain
• CLINICAL_TRIALS study record update · 2007-12-05
  A Retrospective Study to Describe the Incidence of Moderate to Severe Allergic Reactions to Factor IX in Patients With Hemophilia B
• CLINICAL_TRIALS study record update · 2007-12-05
  A Double-Blind, Randomized, Crossover Evaluation of the Pharmacokinetics of Recombinant Human Factor IX (BeneFIX) and a New Formulation of BeneFIX (rFIX-R); and an Open-Label Safety and Efficacy Evaluation of rFIX-R in Previously Treated Patients With Moderate to Severe (FIX:C≤2%) Hemophilia B
• CLINICAL_TRIALS study record update · 2007-08-30
  Post Marketing Study in Haemophilia B Patients Using Nonafact® 100 IU/ml Powder and Solvent for Solution for Injection(Human Coagulation Factor IX)(Human Plasma Derived Factor IX Product, Freeze Dried)
• CLINICAL_TRIALS study record update · 2007-04-04
  A Phase I Safety Study in Subjects With Severe Hemophilia B (Factor IX Deficiency) Using Adeno-Associated Viral Vector to Deliver the Gene for Human Factor IX Into the Liver